Uptake of dodecanedioic acid by isolated rat liver

Clinica Chimica Acta

Volumn 258, Issue 2, 1997, Pages 209-218

  Greco, A V ^a   Mingrone, G ^a   De Gaetano, A ^a   Amigo, L ^b   Puglielli, L ^b   Castagneto, M ^a   Nervi, F ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Dicarboxylic acid; Dodecanedioic acid; HPLC; Isolated liver perfusion; Mathematical models

Indexed keywords

BOVINE SERUM ALBUMIN; CARBON 14;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG UPTAKE; FATTY ACID OXIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; ISOLATED LIVER; ISOTOPE LABELING; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BINDING SITES; DICARBOXYLIC ACIDS; HALF-LIFE; LIVER; MALE; PERFUSION; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE;

EID: 0031575606     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(96)06457-1     Document Type: Article

References (33)

1. [1] Verkade PE, Van der Lee J. Researches on fat metabolism II. Biochem J 1934;28:31-40.
2. [2] Mannaerts GP, Debeer J. Thomas J, et al. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate treated rats. J Biol Chem 1979;254:4585-4595.
3. [3] Kolvraa S, Gregersen N. In vitro studies on the oxidation of medium-chain dicarboxylic acids in rat liver. Biochim Biophys Acta 1986;876:515-525.
4. [4] Leighton F, Bergseth S, Rortveit T et al. Free acetate production by rat hepatocytes during peroxisomal fatty acid and dicarboxylic acid oxidation. J Biol Chem 1989;264:347-350.
5. [5] Suzuki H, Yamada J, Watanabe T, et al. Compartmentation of dicarboxylic acid beta oxidation in rat liver: importance of peroxisomes in the metabolism of dicarboxylic acids. Biochim Biophys Acta 1989;990:25-30.
6. [6] Bergseth S, Poisson JP, Bremer J. Metabolism of dicarboxylic acids in rat hepatocytes. Biochim Biophys Acta 1990;1042:182-187.
7. [7] Lazarow PB, de Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 1976;73:2043-2046.
8. [8] Rognstad R. Estimation of peroxisomal and mitochondrial fatty acid oxidation in rat hepatocytes using tritiated substrates. Biochem J 1991;279:147-150.
9. [9] Kondrup J, Lazarow PB. Flux of palmitate through the peroxisomal and mitochondrial beta-oxidation systems in isolated rat hepatocytes. Biochim Biophys Acta 1985;835:147-153.
10. [10] Tserng KY, Jin SJ. Metabolic conversion of dicarboxylic acids to succinate in rat liver homogenates, a stable isotope tracer study. J Biol Chem 1991:266:2924-2929.
11. [11] Mortensen PB. Dicarboxylic acids and lipid metabolism. Thesis, Aarhus University, 1983.
12. [12] Bergseth S, Hokland BM, Bremer J. Metabolism of dicarboxylic acids in vivo and in the perfused kidney of rat. Biochim Biophys Acta 1988;961:103-109.
13. [13] Passi S, Nazzaro-Porro M, Picardo M, et al. Metabolism of straight, saturated medium chain-length (C9-C12) dicarboxylic acids. J Lipid Res 1983;24:1140-1147.
14. [14] Mingrone G, Greco AV, Nazzaro-Porro M et al. Toxicity of azelaic acid. Drugs Exp Clin Res 1983;9:447-455.
15. [15] Mingrone G, Tacchino RM, Greco AV et al. Preliminary studies of a dicarboxylic acid as an energy substrate in man. J Parenter Enter Nutr 1989; 13:299-305.
16. [16] Mingrone G, Tacchino RM, Castagneto M et al. Use of even-numbered carbon atom dicarboxylic salts in parenteral nutrition as fuel substrate. J Parenter Enter Nutr 1992;16:32-38.
17. [17] Greco AV, Mingrone G, Arcieri Mastromattei E et al. Toxicity of sebacic acid. Drugs Exp Clin Res 1990;16:531-536.
18. [18] Tacchino RM, Mingrone G, Marino F et al. Short-term infusion of azelaic acid vs. intralipid in healthy subjects evaluated by indirect calorimetry. J Parenter Enter Nutr 1990;14:169-172.
19. [19] Mingrone G, Greco AV, Bertuzzi A et al. Tissue uptake and oxidation of disodium sebacate in man. J Parenter Enter Nutr 1991;15:454-459.
20. [20] Bertuzzi A, Gandolfi A, Salinari S et al. Pharmacokinetic analysis of azelaic disodium salt: a proposed substrate for total parenteral nutrition. Clin Pharmacokinet 1991;20:411-419.
21. [21] Greco AV, Mingrone G, Raguso C et al. Metabolic effects and disposition of sebacate, an alternate dicarboxylic fuel substrate. Ann Nutr Metab 1992;36:1-11.
22. [22] Tataranni PA, Mingrone G, De Gaetano A et al. Tracer study of metabolism and tissue distribution of sebacic acid in rats. Ann Nutr Metab 1992;36:296-303.
23. [23] Bertuzzi A, Finotti E, Mingrone G et al. Sebacic acid binding to human plasma albumin. Biochem Pharmacol 1993;45:697-702.
24. [24] Raguso CA, Mingrone G, Greco AV et al. Dicarboxylic acids and glucose utilization in humans: effect of sebacate. J Parenter Enter Nutr 1994;18:9-13.
25. [25] Mingrone G, Greco AV, De Gaetano A et al. Pharmacokinetic profile of dodecanedioic acid, a proposed alternative fuel substrate. J Parenter Enter Nutr 1994;18:225-230.
26. [26] Mingrone G, De Gaetano A, Greco AV et al. Plasma clearance and oxidation of dodecanedioic acid in humans. J Parenter Enter Nutr 1996;20:38-42.
27. [27] Bertuzzi A, Mingrone G, Gandolfi A et al. Pharmacokinetic analysis of dodecanedioic acid in man from bolus data. J Parenter Enter Nutr 1995;19:498-501.
28. [28] Nervi F, Marinovich I, Rigotti A et al. Regulation of biliary cholesterol secretion. Functional relationship between the canalicular and sinusoidal cholesterol secretory pathways in the rat. J Clin Invest 1988;82:1818-1825.
29. [29] Hamilton RL, Berry MN, Williams MC et al. A simple and inexpensive membrane 'lung' for small organ perfusion. J Lipid Res 1974;15:182-186.
30. [30] Ashbrook JD, Spector AA, Fletcher JB. Medium-chain fatty acid binding to human plasma albumin. J Biol Chem 1972;247:7038-7042.
31. [31] Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-667.
32. [32] Spector AA, John K, Fletcher JE. Binding of long-chain fatty acids to bovine serum albumin. J Lipid Res 1969;10:56-67.
33. [33] Spector AA. Fatty acid binding to plasma albumin. J Lipid Res 1975;16:165-179.